SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Patiraki Elisabeth)
 

Sökning: WFRF:(Patiraki Elisabeth) > Complementary and a...

Complementary and alternative medicine use in lung cancer patients in eight European countries

Molassiotis, Alexander (författare)
a School of Nursing, University of Manchester, Manchester, United Kingdom
Panteli, Vassiliki (författare)
Greek Oncology Nursing Society, Athens, Greece
Patiraki, Elisabeth (författare)
Greek Oncology Nursing Society, Athens, Greece
visa fler...
Ozden, Gulten (författare)
Gazi University Hospital, Ankara, Turkey
Platin, Nurgun (författare)
School of Health Sciences, Koc University, Istanbul, Turkey
Madsen, Elin (författare)
Oncology Department, Aarhus University Hospital, Aarhus, Denmark
Browall, Maria (författare)
Sahlgrenska University Hospital, Gothenburg, Sweden
Fernandez-Ortega, Paz (författare)
Institut Català Oncologia ICO, Barcelona, Spain
Pud, Dorit (författare)
Faculty of Social Welfare and Health Studies, University of Haifa, Haifa, Israel
Margulies, Anita (författare)
University Hospital Zürich, Klinik und Poliklinik für Onkologie, Zürich, Switzerland
visa färre...
 (creator_code:org_t)
Elsevier, 2006
2006
Engelska.
Ingår i: Complementary Therapies in Clinical Practice. - : Elsevier. - 1744-3881 .- 1873-6947. ; 12:1, s. 34-39
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • This paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients. 

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Alternative medicine
Complementary medicine
Complementary therapies
Lung cancer
adult
aged
article
cross-sectional study
decision making
epidemiology
Europe
family
female
friend
human
Israel
lung tumor
male
methodology
middle aged
motivation
patient attitude
patient education
psychological aspect
questionnaire
socioeconomics
statistics
treatment outcome
Turkey (republic)
utilization review
Aged
80 and over
Cross-Sectional Studies
Friends
Health Care Surveys
Humans
Lung Neoplasms
Patient Acceptance of Health Care
Questionnaires
Socioeconomic Factors
Turkey

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy